April 19, 2017, Amsterdam, The Netherlands: The European Association for the Study of the Liver (EASL) today announced that four new Clinical Practice Guidelines (CPGs) will be presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, and published in the Journal of Hepatology, EASL's official journal.
CPGs define the use of diagnostic, therapeutic and preventive modalities, including non-invasive and invasive procedures, in the management of patients with various liver diseases. They are intended to assist physicians and other healthcare providers, as well as patients and interested individuals, in the clinical decision making process by describing a range of generally accepted approaches for the diagnosis, treatment and prevention of specific liver diseases.
The new CPGs include:
Revised guidelines on the 'Management of Hepatitis B virus infection'
- Session title: CPG session – HBV
- Time and date of presentation: Thursday 20 April 2017, 12:30 – 13:15 CET
- Chairs: Pietro Lampertico (Italy), Frank Tacke (Germany)
New guidelines on the 'Management of Acute (fulminant) Liver Failure'
- Session title: CPG session – ALF, PSC, PBC
- Time and date of presentation: Sunday 23 April 2017, 10:30 – 11:30 CET
- Chair: Marco Marzioni (Italy)
New ESGE/EASL guidelines on the 'Role of endoscopy in Primary Sclerosing Cholangitis'
- Session title: CPG session – ALF, PSC, PBC
- Time and date of presentation: Sunday 23 April 2017, 10:30 – 11:30 CET
- Chair: Marco Marzioni (Italy)
New guidelines on 'The treatment and management of patients with Primary Biliary Cholangitis'
- Session title: CPG session – ALF, PSC, PBC
- Time and date of presentation: Sunday 23 April 2017, 10:30 – 11:30 CET
- Chair: Marco Marzioni (Italy)
"The EASL Primary Biliary Cholangitis guidelines are meant to support clinicians in establishing a long-term commitment with patients and their disease, providing indications on how to stratify the risk from diagnosis to disease progression. The guidelines will also help identify which patients require second line treatment, in which advances are fortunately being made," said Prof Marco Marzioni, Professor of Gastroenterology, Università Politecnica delle Marche – "Ospedali Riuniti" University Hospital of Ancona, Italy and one of the authors of the guidelines. He continued, "The EASL-ESGE guidelines have been developed by the two societies to identify the optimal approach for the management of Primary Sclerosing Cholangitis. As extra-hepatic bile ducts are involved in the disease, a multi-disciplinary approach is a key factor for the success of management. The guidelines provide a tool to fine tune the endoscopic and medical treatments of patients with Primary Sclerosing Cholangitis."
###
About The International Liver Congress™
This annual congress is the biggest event in the EASL calendar, attracting scientific and medical experts from around the world to learn about the latest in liver research. Attending specialists present, share, debate and conclude on the latest science and research in hepatology, working to enhance the treatment and management of liver disease in clinical practice. This year, the congress is expected to attract approximately 10,000 delegates from all corners of the globe. The International Liver Congress™ 2017 will take place from April 19 – 23, at the RAI Amsterdam, Amsterdam, The Netherlands.
About the Journal of Hepatology
The Journal of Hepatology is the official journal of the European Association for the Study of the Liver (EASL). It publishes original papers, reviews, case reports, and letters to the Editor concerned with clinical and basic research in the field of hepatology. http://www.journal-of-hepatology.eu
About The European Association for the Study of the Liver (EASL)
Since its foundation in 1966, this not-for-profit organisation has grown to over 4,000 members from all over the world, including many of the leading hepatologists in Europe and beyond. EASL is the leading liver association in Europe, having evolved into a major European Association with international influence, with an impressive track record in promoting research in liver disease, supporting wider education and promoting changes in European liver policy.
Contact
For more information, please contact the ILC Press Office at:
Email: [email protected]
Telephone: +44 (0)7841 009 252
Media Contact
ILC press office
[email protected]
44-078-410-09252
@EASLnews
http://www.easl.ch/
############
Story Source: Materials provided by Scienmag
